Sale!

RTN2 Gene SPG12 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The RTN2 Gene SPG12 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the RTN2 gene associated with hereditary spastic paraplegia type 12 (SPG12). This comprehensive genetic analysis utilizes next-generation sequencing technology to detect specific genetic variations that cause progressive neurological symptoms including muscle stiffness, walking difficulties, and lower limb weakness. The test provides crucial information for accurate diagnosis, family planning decisions, and personalized treatment approaches. Results are typically available within 3-4 weeks from sample collection. This advanced genetic testing is available for $500 USD, offering significant savings from the regular $700 price. The test requires a simple blood sample or extracted DNA, making it accessible for patients across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

RTN2 Gene SPG12 NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Spastic Paraplegia

The RTN2 Gene SPG12 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations responsible for hereditary spastic paraplegia type 12 (SPG12). This advanced testing methodology provides crucial insights for patients and families affected by progressive neurological conditions, enabling accurate diagnosis and informed medical decision-making.

What Does the RTN2 Gene SPG12 Test Measure?

This sophisticated genetic analysis specifically targets the RTN2 (reticulon 2) gene, which plays a critical role in maintaining the structural integrity of neuronal cells. The test utilizes next-generation sequencing (NGS) technology to comprehensively examine the entire coding region of the RTN2 gene, identifying:

  • Point mutations and single nucleotide variations
  • Small insertions and deletions affecting gene function
  • Copy number variations impacting gene dosage
  • Pathogenic variants associated with SPG12 development

Who Should Consider RTN2 Gene SPG12 Testing?

This genetic test is particularly recommended for individuals experiencing symptoms suggestive of hereditary spastic paraplegia, including:

  • Progressive muscle stiffness and spasticity in lower limbs
  • Difficulty walking or changes in gait pattern
  • Muscle weakness affecting mobility and daily activities
  • Family history of similar neurological symptoms
  • Unexplained progressive neurological deterioration
  • Children or young adults developing walking difficulties

Clinical Benefits of Genetic Testing

Undergoing RTN2 Gene SPG12 testing provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Confirms or rules out SPG12 with high precision
  • Family Planning: Enables informed reproductive decisions for at-risk families
  • Personalized Treatment: Guides targeted therapeutic interventions
  • Prognostic Information: Helps predict disease progression and outcomes
  • Genetic Counseling: Supports comprehensive family risk assessment
  • Research Contribution: Advances understanding of neurological disorders

Understanding Your Test Results

Your RTN2 Gene SPG12 test results will be carefully interpreted by our expert genetic specialists. The report typically includes:

  • Positive Result: Indicates the presence of a pathogenic RTN2 mutation, confirming SPG12 diagnosis
  • Negative Result: Suggests absence of known RTN2 mutations, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

All results include detailed explanations and recommendations for next steps, with genetic counseling available to help you understand the implications for you and your family.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Accessibility

We proudly offer RTN2 Gene SPG12 NGS Genetic DNA testing across our extensive network of facilities throughout the United States. Our state-of-the-art laboratories serve patients in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. With convenient sample collection options and rapid turnaround times of 3-4 weeks, we ensure accessible genetic testing for all patients requiring neurological genetic evaluation.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about hereditary spastic paraplegia impact your quality of life. Our comprehensive RTN2 Gene SPG12 testing provides the answers you need for informed medical decisions and personalized care planning. Contact our genetic specialists today to schedule your test and begin your journey toward genetic clarity.

Book Your Test Today: Call +1(267) 388-9828 or WhatsApp our genetic counseling team to schedule your appointment and discuss your testing options. Our compassionate professionals are ready to guide you through every step of the genetic testing process.